Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) EPS (Weighted Average and Diluted) (2019 - 2025)

Neuronetics (STIM) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with -$0.13 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 70.45% to -$0.13 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.83, a 31.4% increase, with the full-year FY2024 number at -$1.38, down 31.43% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.13 for Q3 2025 at Neuronetics, up from -$0.15 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.13 in Q3 2025 to a low of -$0.44 in Q3 2024.
  • A 5-year average of -$0.29 and a median of -$0.3 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 100.0% in 2024, then skyrocketed 70.45% in 2025.
  • Neuronetics' EPS (Weighted Average and Diluted) stood at -$0.28 in 2021, then decreased by 7.14% to -$0.3 in 2022, then soared by 40.0% to -$0.18 in 2023, then crashed by 88.89% to -$0.34 in 2024, then soared by 61.76% to -$0.13 in 2025.
  • Per Business Quant, the three most recent readings for STIM's EPS (Weighted Average and Diluted) are -$0.13 (Q3 2025), -$0.15 (Q2 2025), and -$0.21 (Q1 2025).